Erik Harris, EVP & Chief Commercial Officer at Ultragenyx Pharmaceutical Inc. (RARE), sold 5,426 shares at $66.62 ($361K) on 2022-03-01, disclosed to the SEC on 2022-03-03.
Open-market sale of $361k RARE by EVP & Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $66.62 | 2,713 | $181K | 50.0% |
| 2 | $66.62 | 2,713 | $181K | 50.0% |
| Total | $66.62 avg | 5,426 | $361K | 100% |
| Filing → |
| RARE | SELL | 2024-03-05 | $513K | — | Filing → |
| RARE | SELL | 2023-09-06 | $228K | — | Filing → |
| RARE | SELL | 2023-06-21 | $15K | — | Filing → |